Albemarle Aktie News

Lithium glut persists, pressuring Albemarle Corporation's revenue and share price. China's low-cost production continues to dominate and disrupt global lithium markets. Cost-cutting efforts have restored positive free cash flow and EBITDA for ALB.

The commodities market has taken investors by surprise in the past few days, especially as the prices of gold and silver have surged, shaking up most beliefs about where money should be flowing. The sort of conclusions that can be drawn from this behavior are several, but one fact that stands out is that some stocks in the basic materials sector will likely have to play catch-up to these runs.

CHARLOTTE, N.C., June 3, 2025 /PRNewswire/ -- Albemarle Corporation (NYSE: ALB), a global leader in providing essential elements for mobility, energy, connectivity, and health, today published its 2024 Sustainability Report.

Nucor (NUE), Albemarle (ALB), and West Pharmaceutical Services (WST) have provided reliable dividends and growth, and Wall Street sees them growing even more over the next year.

Dividend Aristocrats have slightly outperformed the S&P 500 year-to-date, despite underperforming in April and May. Dividend growth remains robust, with 41 of 69 Aristocrats announcing increases in 2025 and the average growth rate at 4.75%. 22 Aristocrats appear both undervalued and offer a projected long-term annualized return of at least 10%, based on dividend yield theory and earnings growth.

Many S&P 500 Dividend Aristocrats remain overvalued, but select high-yield 'Dogs' like Realty Income and Amcor offer attractive entry points for income investors. Analyst forecasts suggest the top ten Aristocrat Dogs could deliver 16% to 38% net gains by May 2026, with average risk below the market. Caution: Fourteen Aristocrats have negative free cash flow margins, making their dividends less ...

Price action is typically a great indicator of a company's present and future, as the market prices in today's available information, along with the next three to six months of fundamentals. A stock's price is a consensus view of where the collective thought is for the business in question.

Albemarle's Q1'25 results showed resilience with strong cost cuts and adjusted EBITDA despite a cycle low in sales. Lithium prices are unsustainably low, with a return to higher prices needed to grow long-term supply to meet ultimate demand levels. The stock is at a prime valuation of 3x EV/EBITDA targets, based on lithium returning to just Q4'23 prices.